-
effectivehealthcare-admin.ahrq.gov/health-topics/health-screening
April 07, 2025 - Some conditions that doctors commonly screen for include
Breast cancer and cervical cancer in
-
effectivehealthcare-admin.ahrq.gov/products/skin-cancer/research
May 01, 2019 - Metastatic Bone Disease: Effectiveness and Harms
Systematic Review
Jan 31, 2023
Partial Breast … Irradiation for Breast Cancer
Page last reviewed May 2019
Page originally
-
effectivehealthcare-admin.ahrq.gov/products/renal-cancer/research
December 01, 2019 - Metastatic Bone Disease: Effectiveness and Harms
Systematic Review
Jan 31, 2023
Partial Breast … Irradiation for Breast Cancer
Systematic Review
Nov 12, 2020
Management of Primary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/politi.pdf
December 26, 2012 - Preference-‐Sensitive Decisions:
• BCS vs. mastectomy for average risk patients with early stage breast … • Recommends against breast self-‐exam (BSE).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - What is the available evidence concerning levels in maternal serum/blood, fetal/infant
serum/blood, breast … gain, tachycardia, hypertension,
gastrointestinal)
• Preterm labor, cesarean section
• Reduced breast … gain, tachycardia, hypertension,
gastrointestinal)
• Preterm labor, cesarean section
• Reduced breast … analog” OR octreotide)
AND
(Pharmacokinetic* OR pharmacodynamic* OR "Pharmacokinetics"[Mesh] OR “Breast … OR #18 OR #19
#19: 'amnion fluid'/de
#18: 'umbilical cord blood'/de
#17: 'fetus blood'/de
#16: 'breast
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
June 01, 2012 - For example, the Oncotype Dx® test evaluates the tumor genome of excised tumors from patients with breast … BRCA1 and BRCA2 mutations can influence the risk for multiple cancer types including breast, ovarian, … Similarly, BRCA1 and BRCA2 mutations can increase the risk of a number of cancer types including breast … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors. … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
June 01, 2012 - For example, the Oncotype Dx® test evaluates the tumor genome of excised tumors from patients with breast … BRCA1 and BRCA2 mutations can influence the risk for multiple cancer types including breast, ovarian, … Similarly, BRCA1 and BRCA2 mutations can increase the risk of a number of cancer types including breast … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors. … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors.
-
effectivehealthcare-admin.ahrq.gov/products/uterine-fibroids/research-protocol
May 01, 2019 - Serono, Inc.), Rockland, MA, USA
Goserelin Acetate, Zoladex®
FDA-labeled indications : Breast … combination with flutamide for locally confined stage B2-C disease
Non-FDA labeled indications : Breast … central precocious puberty; endometriosis; advance prostate cancer
Non-FDA labeled indications : Breast … cancer, following disease progression while on an aromatase inhibitor; neoadjuvant therapy in breast … cancer in premenopausal women with breast cancer; endometriosis, dysfunctional uterine bleeding; uterine
-
effectivehealthcare-admin.ahrq.gov/products/head-neck-cancer-update/research
December 01, 2019 - Metastatic Bone Disease: Effectiveness and Harms
Systematic Review
Jan 31, 2023
Partial Breast … Irradiation for Breast Cancer
Systematic Review
Nov 03, 2021
Prehabilitation and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - events
o Cancer (incident or mortality)
Total cancer
Prostate cancer
Colorectal cancer
Breast … outcomes
Cancer intermediate outcomes (colorectal adenoma, aberrant crypt cells, and
mammographic breast … Arrow 1
Arrow 2
Arrow 2
Arrow 3
Arrow 4 Arrow 5
Arrow 5
Arrow 6
Arrow 6
Immune
outcomes
Breast … • Cancer intermediate outcomes, including colorectal adenoma aberrant crypt foci and
mammographic breast … density (quantitative whole-breast density)
• Immune function clinical outcomes (infectious diseases
-
effectivehealthcare-admin.ahrq.gov/health-topics/anabolic-steroids
They include
Acne
Breast growth and shrinking of testicles in men
Voice deepening and growth
-
effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/protocol
March 01, 2024 - life, partner satisfaction Serum hormone concentration, Stress incontinence KQ3&5: Safety outcomes : breast … cancer, breast cancer recurrence or progression, breast tenderness, cardiovascular risk, endometrial … Systemic adverse events : chronic pain, stroke; VTE (DVT or PE); death; hot flashes; headache; breast … Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus … The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer.
-
effectivehealthcare-admin.ahrq.gov/health-topics/menopause
February 19, 2025 - This includes whether you are at risk for heart disease , osteoporosis , or breast cancer .
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - pain, poor milk
supply, maternal breast engorgement, and
refusing the breast.2 Ineffective latch is … We sought information on
outcomes related to breast- and bottle-feeding and related
to tongue-tie in … Bottle feedings to supplement breast
feeding decreased over time in the case series. … Immediate nipple pain
relief after frenotomy in breast-fed infants with ankyloglossia:
a randomized … Tongue tie division in infants with breast
feeding difficulties.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - Rockland, MA
USA
Goserelin Acetate
Zoladex®
FDA-labeled indications: Breast cancer …
flutamide for locally confined stage B2-C
disease
Non-FDA labeled indications:
Breast … following disease progression while on
an aromatase
inhibitor;; neoadjuvant therapy in breast … cancer in
premenopausal women with breast cancer;;
endometriosis, dysfunctional uterine … Wilmington, DE
USA
Raloxifene
Hydrochloride
Evista®
FDA-labeled indications:
Breast
-
effectivehealthcare-admin.ahrq.gov/products/breastfeeding/research
February 01, 2019 - Breastfeeding is associated with reduced maternal risk of breast and ovarian cancer, hypertension, and … that ever breastfeeding or breastfeeding for longer durations may be associated with lower rates of breast
-
effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/protocol
May 01, 2020 - What is the available evidence concerning levels in maternal serum/blood, fetal/infant serum/blood, breast … Reduced breast milk production.
Symptoms related to withdrawal of medication. … Reduced breast milk production.
Symptoms related to withdrawal of medication. … Appendix A: Literature Search
Search 1 – headache treatment
PubMed
(“Breast Feeding”[Mesh] OR “ … 'fetus growth'/de
#1: 'breastfeeding'/exp OR 'breastfeeding'
Search 2 – SRs of AEs
PubMed
(“Breast
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - , stroke, or venous thromboembolism;
gallbladder disease; osteoporotic fractures; or
endometrial, breast … stroke, or venous thromboembolism; gallbladder
disease; osteoporotic fractures; or endometrial,
breast … Trials enrolling women with preexisting
conditions (e.g., heart disease, lupus, fibromyalgia, breast … We did not include studies examining effects among
breast cancer survivors—women frequently affected … Placebo Strength of Evidence
Breast cancer — Vitamin E High
Breast cancer SSRI Insufficient
Colorectal
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-radiation/research
December 01, 2019 - Metastatic Bone Disease: Effectiveness and Harms
Systematic Review
Jan 31, 2023
Partial Breast … Irradiation for Breast Cancer
Page last reviewed December 2019
Page
-
effectivehealthcare-admin.ahrq.gov/health-topics/puberty
In girls:
The first sign of puberty is usually breast development.